TY - JOUR
T1 - Nonoperative Management of Venous Leg Ulcers
T2 - Evolving Role of Skin Substitutes
AU - Moneta, Gregory L.
PY - 1999/3
Y1 - 1999/3
N2 - Chronic venous leg ulcers markedly influence the physical, financial, and psychologic wellbeing of patients and result in an estimated 2 million lost workdays annually. Despite a wide variety of therapeutic options, venous leg ulcers remain a substantial management challenge to health care professionals. Although no consensus on compression therapy exists, it remains a primary treatment of edema and ulceration secondary to venous disease. Recently, biotechnology-derived skin substitutes have been developed to help stimulate local wound healing. These range in composition from an epidermal or dermal layer to a complete, bilayered living skin construct. This review focuses on nonoperative treatment options for venous ulcers, particularly the evolving roles of newer treatment options including skin substitutes and growth factor/cytokine preparations. The development and characteristics of these emerging therapies as well as clinical experience with and options for their use in the treatment of chronic venous ulcers are reviewed.
AB - Chronic venous leg ulcers markedly influence the physical, financial, and psychologic wellbeing of patients and result in an estimated 2 million lost workdays annually. Despite a wide variety of therapeutic options, venous leg ulcers remain a substantial management challenge to health care professionals. Although no consensus on compression therapy exists, it remains a primary treatment of edema and ulceration secondary to venous disease. Recently, biotechnology-derived skin substitutes have been developed to help stimulate local wound healing. These range in composition from an epidermal or dermal layer to a complete, bilayered living skin construct. This review focuses on nonoperative treatment options for venous ulcers, particularly the evolving roles of newer treatment options including skin substitutes and growth factor/cytokine preparations. The development and characteristics of these emerging therapies as well as clinical experience with and options for their use in the treatment of chronic venous ulcers are reviewed.
UR - http://www.scopus.com/inward/record.url?scp=0033043853&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033043853&partnerID=8YFLogxK
U2 - 10.1177/153857449903300217
DO - 10.1177/153857449903300217
M3 - Article
AN - SCOPUS:0033043853
SN - 1538-5744
VL - 33
SP - 197
EP - 210
JO - Vascular and Endovascular Surgery
JF - Vascular and Endovascular Surgery
IS - 2
ER -